Effect of Ethyl Pyruvate on Paclitaxel-Induced Neuropathic Pain in Rats
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background:Although paclitaxel is a widely used chemotherapeutic agent for the treatment of solid cancers, side effects such as neuropathic pain lead to poor compliance and discontinuation of the therapy. Ethyl pyruvate (EP) is known to have analgesic effects in several pain models and may inhibit apoptosis. The present study was designed to investigate the analgesic effects of EP on mechanical allodynia and apoptosis in dorsal root ganglion (DRG) cells after paclitaxel administration. Methods:Rats were randomly divided into 3 groups: 1) a control group, which received only vehicle; 2) a paclitaxel group, which received paclitaxel; and 3) an EP group, which received EP after paclitaxel administration. Mechanical allodynia was tested before and at 7 and 14 days after final paclitaxel administration. Fourteen days after paclitaxel treatment, DRG apoptosis was determined by activated caspase-3 immunoreactivity (IR). Results:Post-treatment with EP did not significantly affect paclitaxel-induced allodynia, although it tended to slightly reduce sensitivities to mechanical stimuli after paclitaxel administration. After paclitaxel administration, an increase in caspase-3 IR in DRG cells was observed, which was co-localized with NF200-positive myelinated neurons. Post-treatment with EP decreased the paclitaxel-induced caspase-3 IR. Paclitaxel administration or post-treatment with EP did not alter the glial fibrillary acidic protein IRs in DRG cells. Conclusions:Inhibition of apoptosis in DRG neurons by EP may not be critical in paclitaxel-induced mechanical allodynia.
Abstract
Background:Although paclitaxel is a widely used chemotherapeutic agent for the treatment of solid cancers, side effects such as neuropathic pain lead to poor compliance and discontinuation of the therapy. Ethyl pyruvate (EP) is known to have analgesic effects in several pain models and may inhibit apoptosis. The present study was designed to investigate the analgesic effects of EP on mechanical allodynia and apoptosis in dorsal root ganglion (DRG) cells after paclitaxel administration. Methods:Rats were randomly divided into 3 groups: 1) a control group, which received only vehicle; 2) a paclitaxel group, which received paclitaxel; and 3) an EP group, which received EP after paclitaxel administration. Mechanical allodynia was tested before and at 7 and 14 days after final paclitaxel administration. Fourteen days after paclitaxel treatment, DRG apoptosis was determined by activated caspase-3 immunoreactivity (IR). Results:Post-treatment with EP did not significantly affect paclitaxel-induced allodynia, although it tended to slightly reduce sensitivities to mechanical stimuli after paclitaxel administration. After paclitaxel administration, an increase in caspase-3 IR in DRG cells was observed, which was co-localized with NF200-positive myelinated neurons. Post-treatment with EP decreased the paclitaxel-induced caspase-3 IR. Paclitaxel administration or post-treatment with EP did not alter the glial fibrillary acidic protein IRs in DRG cells. Conclusions:Inhibition of apoptosis in DRG neurons by EP may not be critical in paclitaxel-induced mechanical allodynia.
참고문헌 (41)
- Jordan MA, "Microtubules as a target for anticancer drugs", Nat Rev Cancer, 4, pp.253~265 (2004)
- Forsyth PA, "Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing", J Neurooncol, 35, pp.47~53 (1997)
- Postma TJ, "Paclitaxel-induced neuropathy", Ann Oncol, 6, pp.489~494 (1995)
- Cavaletti G, "Peripheral neurotoxicity of taxol in patients previously treated with cisplatin", Cancer, 75, pp.1141~1150 (1995)
- Boyette-Davis J, "Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline", Pain, 152, pp.308~313 (2011)
- Siau C, "Paclitaxel- and vincristineevoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells", Exp Neurol, 201, pp.507~514 (2006)
- Melli G, "Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy", Exp Neurol, 214, pp.276~284 (2008)
- Scuteri A, "Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells", Anticancer Res, 26, pp.1065~1070 (2006)
- Peters CM, "An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat", Brain Res, 1168, pp.46~59 (2007)
- Zimmermann M, "Pathobiology of neuropathic pain", Eur J Pharmacol, 429, pp.23~37 (2001)
- Sekiguchi M, "Comparison of neuropathic pain and neuronal apoptosis following nerve root or spinal nerve compression", Eur Spine J, 18, pp.1978~1985 (2009)
- Sung Hoon Kim, "Tumor Necrosis Factor-alpha and Apoptosis Following Spinal Nerve Ligation Injury in Rats", The Korean Journal of Pain, 24(4), pp.185~190 (2011), 대한통증학회
- Yu YM, "Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window", STROKE, 36, pp.2238~2243 (2005), LIPPINCOTT WILLIAMS & WILKINS
- Wang Q, "Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits", Anesthesiology, 110, pp.1279~1286 (2009)
- Genovese T, "Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury", Shock, 32, pp.217~227 (2009)
- Guo J, "Effects of ethyl pyruvate on myocardial apoptosis and expression of Bcl-2 and Bax proteins after ischemia-reperfusion in rats", J Huazhong Univ Sci Technolog Med Sci, 28, pp.281~283 (2008)
- Tsung A, "Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis", Transplantation, 79, pp.196~204 (2005)
- Dae Kee Choi, "Effects of Ethyl Pyruvate on Allodynia, TNF-α Expression, and Apoptosis in the Dorsal Root Ganglion after Spinal Nerve Ligation Injury", The Korean Journal of Pain, 25(4), pp.213~220 (2012), 대한통증학회
- Lee MJ, "Ethyl pyruvate attenuates formalin-induced inflammatory nociception by inhibiting neuronal ERK phosphorylation", Mol Pain, 8, pp.40~ (2012)
- Jacobs CC, "Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses", Equine Vet J (2012)
- Matsumoto M, "Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin", J Pharmacol Exp Ther, 318, pp.735~740 (2006)
- Polomano RC, "A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel", Pain, 94, pp.293~304 (2001)
- Choi JS, "Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 394(3), pp.854~858 (2010), ACADEMIC PRESS INC ELSEVIER SCIENCE
- Yang R, "Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis", J Surg Res, 153, pp.302~309 (2009)
- Li Y, "Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers", Pain, 85, pp.493~502 (2000)
- Jeong Il Choi, "Antiallodynic Effect of Thalidomide and Morphine on Rat Spinal Nerve Ligation-induced Neuropathic Pain", The Korean Journal of Pain, 23(3), pp.172~178 (2010), 대한통증학회
- Chaplan SR, "Quantitative assessment of tactile allodynia in the rat paw", J Neurosci Methods, 53, pp.55~63 (1994)
- Flatters SJ, "Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction", Pain, 122, pp.245~257 (2006)
- Pascual D, "A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats", Pain, 118, pp.23~34 (2005)
- Xiao WH, "Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine", Pain, 135, pp.262~270 (2008)
- Zhang J, "Comparison of paclitaxel and cisplatin effects on the slowly adapting type I mechanoreceptor", Brain Res, 1214, pp.50~57 (2008)
- Figueroa-Masot XA, "Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation", J Neurosci, 21, pp.4657~4667 (2001)
- Jang HJ, "Taxol induces oxidative neuronal cell death by enhancing the activity of NADPH oxidase in mouse cortical cultures", NEUROSCIENCE LETTERS, 443(1), pp.17~22 (2008), ELSEVIER IRELAND LTD
- Chen M, "Initiator caspases in apoptosis signaling pathways", Apoptosis, 7, pp.313~319 (2002)
- Joseph EK, "Caspase signalling in neuropathic and inflammatory pain in the rat", Eur J Neurosci, 20, pp.2896~2902 (2004)
- Burkhart CA, "Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity", Cancer Res, 54, pp.5779~5782 (1994)
- Manthey CL, "Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages", J Immunol, 149, pp.2459~2465 (1992)
- Kiguchi N, "Chemokines and cytokines in neuroinflammation leading to neuropathic pain", Curr Opin Pharmacol, 12, pp.55~61 (2012)
- Wang XM, "Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy", Cytokine, 59, pp.3~9 (2012)
- Zhang H, "Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy", J Pain, 13, pp.293~303 (2012)
- Burgos E, "Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells", Eur J Pharmacol, 682, pp.62~72 (2012)